B. Sangro

Hepatology · 2011–2022

A researcher in the Science corpus: 13 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom B. Sangro trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Jordi Bruix1 , 2
  2. J. Llovet
  3. I. Crispe
  4. Robert Schreiber
  5. D. Pardoll

Who trusts B. Sangro overall

  1. J. Llovet

Papers from B. Sangro's perspective

Ordered by how strongly the researchers B. Sangro trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
  2. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion (Science)
  3. Immunosuppressive strategies that are mediated by tumor cells. (Annual Review of Immunology)
  4. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. (Gastroenterology)
  5. The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
  6. PD-L2 is a second ligand for PD-1 and inhibits T cell activation (Nature Immunology)
  7. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1 (Journal of Experimental Medicine)
  8. Loss of PTEN promotes resistance to T cell-mediated immunotherapy (Cancer Discovery)
  9. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival (Hepatology)
  10. Neoantigens in cancer immunotherapy (Science)

Their papers